5th Annual Partnerships in Clinical Trials Congress (PCT) and Exhibition

Posted:
15
August 2006

Win a VIP invite to the Partnerships in Clinical Trials congress (PCT), Belgium including:

  • Delegate pass for the duration of the event
  • Travel and accommodation costs

Richmond Pharmacology will be exhibiting at this years PCT congress 13th-15th November 2006, Brussels Expo, Belgium www.ct-partnerships.com.Managing Director Dr Jorg Taubel of Richmond Pharmacology is on the panel of guest speakers and will be covering the topic:'Effective Partnering between Sponsors & Niche Providers'Examining:

  • What niche providers can deliver that global CROs cannot
  • How do partnerships between smaller sponsors & niche providers benefit both
  • The role niche providers play in global clinical trials

If you are planning to attend the conference then please take a look at our prize draw below:We are running a prize draw to win a VIP invite to the PCT event which includes:

  • Delegate pass for 2 days for 1 guest
  • Travel and accommodation costs for the duration of the event for 1 guest

To attend the conference as a guest of Richmond Pharmacology why not enter the prize draw below to be in with a chance to win.To enter, click here

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more